[The use of certain new O-benzoquinone derivatives as acceptor substrates in enzymatic oxidation of NADH]. 1977

L V Volod'ko, and P A Matusevich, and A A Min'ko, and E P Titovets

A possibility of the use of new aliphatic and aminoarylic o-benzoquinone derivatives as acceptor substrates in NADH oxidation catalyzed by NAD(P)H: (acceptor)-oxidoreductase (EC 1.6.99.2) was demonstrated. The kinetic mechanism of this reaction was studied in a monosubstrate approach and the effective kinetic constants were determined. The stability of these o-benzoquinone derivatives in the oxidation-reduction reactions, including anzymic reduction and subsequent auto-oxidation of their diphenolic forms by oxygen, was substantiated using spectrophotometric techniques.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009243 NAD A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed) Coenzyme I,DPN,Diphosphopyridine Nucleotide,Nadide,Nicotinamide-Adenine Dinucleotide,Dihydronicotinamide Adenine Dinucleotide,NADH,Adenine Dinucleotide, Dihydronicotinamide,Dinucleotide, Dihydronicotinamide Adenine,Dinucleotide, Nicotinamide-Adenine,Nicotinamide Adenine Dinucleotide,Nucleotide, Diphosphopyridine
D009247 NADH, NADPH Oxidoreductases A group of oxidoreductases that act on NADH or NADPH. In general, enzymes using NADH or NADPH to reduce a substrate are classified according to the reverse reaction, in which NAD+ or NADP+ is formally regarded as an acceptor. This subclass includes only those enzymes in which some other redox carrier is the acceptor. (Enzyme Nomenclature, 1992, p100) EC 1.6. Oxidoreductases, NADH, NADPH,NADPH Oxidoreductases NADH,Oxidoreductases NADH, NADPH
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011808 Quinone Reductases NAD(P)H:(quinone acceptor) oxidoreductases. A family that includes three enzymes which are distinguished by their sensitivity to various inhibitors. EC 1.6.99.2 (NAD(P)H DEHYDROGENASE (QUINONE);) is a flavoprotein which reduces various quinones in the presence of NADH or NADPH and is inhibited by dicoumarol. EC 1.6.99.5 (NADH dehydrogenase (quinone)) requires NADH, is inhibited by AMP and 2,4-dinitrophenol but not by dicoumarol or folic acid derivatives. EC 1.6.99.6 (NADPH dehydrogenase (quinone)) requires NADPH and is inhibited by dicoumarol and folic acid derivatives but not by 2,4-dinitrophenol. Menaquinone Reductases,Reductases, Menaquinone,Reductases, Quinone
D011809 Quinones Hydrocarbon rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

L V Volod'ko, and P A Matusevich, and A A Min'ko, and E P Titovets
March 1987, Biokhimiia (Moscow, Russia),
L V Volod'ko, and P A Matusevich, and A A Min'ko, and E P Titovets
January 1987, Voprosy meditsinskoi khimii,
L V Volod'ko, and P A Matusevich, and A A Min'ko, and E P Titovets
January 1954, The Journal of the Egyptian Medical Association,
L V Volod'ko, and P A Matusevich, and A A Min'ko, and E P Titovets
December 2022, Biotech (Basel (Switzerland)),
L V Volod'ko, and P A Matusevich, and A A Min'ko, and E P Titovets
January 1987, Archivum immunologiae et therapiae experimentalis,
L V Volod'ko, and P A Matusevich, and A A Min'ko, and E P Titovets
September 1985, Chemical & pharmaceutical bulletin,
L V Volod'ko, and P A Matusevich, and A A Min'ko, and E P Titovets
July 1987, Biochemical and biophysical research communications,
L V Volod'ko, and P A Matusevich, and A A Min'ko, and E P Titovets
January 1952, Giornale di batteriologia e immunologia,
L V Volod'ko, and P A Matusevich, and A A Min'ko, and E P Titovets
January 1959, Neoplasma,
L V Volod'ko, and P A Matusevich, and A A Min'ko, and E P Titovets
December 2002, Biological chemistry,
Copied contents to your clipboard!